<DOC>
	<DOCNO>NCT02257957</DOCNO>
	<brief_summary>Dry eye chronic condition decrease function affect visual function severe discapacity treatment base artificial eye drop . Platelet rich plasma emerge strategy cellular restoration , purpose study evaluate effect lacrimal production safety intervention patient severe dry eye .</brief_summary>
	<brief_title>Platelet -Rich Plasma ( PRP ) Injection Treatment Severe Dry Eye</brief_title>
	<detailed_description>Dry eye chronic condition decrease function affect visual function severe discapacity treatment base artificial eye drop . Platelet rich plasma emerge strategy cellular restoration , purpose study evaluate effect lacrimal production safety intervention patient severe dry eye .</detailed_description>
	<mesh_term>Keratoconjunctivitis Sicca</mesh_term>
	<mesh_term>Dry Eye Syndromes</mesh_term>
	<mesh_term>Sjogren 's Syndrome</mesh_term>
	<mesh_term>Hyaluronic Acid</mesh_term>
	<mesh_term>Ophthalmic Solutions</mesh_term>
	<mesh_term>Tetrahydrozoline</mesh_term>
	<criteria>• Patients symptomatic Dry eye Shirmer ≤10 mm 5 min BUT ≤10 second Corneal stain ≥3 Age range : 18 year old . Both gender ethnic group comparable local community . Able understand willing sign write informed consent Able willing cooperate investigational plan . Able willing complete mandatory followup visit . • Patients currently engage another clinical trial , unwilling unable give consent , accept randomization , return schedule visit . Children 18 . Pregnant woman expect pregnant study . Systemic immune deficient condition AIDS systemic immunosuppressant . Concomitant use systemic antibiotic steroid . Contact lens wear Active ocular infection allergy Unable close eye uncontrolled blinking</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2014</verification_date>
</DOC>